Cambodian Thalassemia kids given new lives after Indian help.
With a bone marrow transplant being the only cure for Thalassemia, it becomes very important to find a matching donor for such treatment.
'It is highly unlikely to find an unrelated donor for Cambodian descent patients as there is no Cambodian donor registry and number of Cambodian donors in other registries are almost negligible', said c, the head of paediatric oncology, haematology and bone marrow transplants at Mazumdar Shaw Cancer Centre at Narayana Health City. 'Chances of a match with other ethnic backgrounds is extremely low.'
It was a huge shock for the couple from Cambodia to have two consecutive children - both girls, suffering from Thalassemia - a potentially lethal disease. Both sisters were diagnosed with Thalassemia major - a disease that requires life-long blood transfusion every few weeks. 'Most of the affected patients usually die in the second to fourth decade of life, ' Dr Bhat said.
Fortunately, almost eight years after the second child was born, the family was blessed with a baby boy who did not suffer from Thalassemia. The father, a doctor by profession, had made every possible effort to provide the best care to both his affected daughters.
However, it was getting difficult for him in Cambodia. Giving adequate, safe and effective blood transfusions and managing the complications of iron overload was becoming a challenge to the family. They learned that a bone marrow transplant would be the only cure for the condition.
They began their search for a centre with experience in paediatric bone marrow transplants. Their research led to Narayana Health City in Bengaluru and Dr Bhat, who has remarkable experience in treating complex cases of blood disorders in children. The centre is also known for its innovative techniques in Haplo identical (half-matched) bone marrow transplants.
Affirming that a bone marrow transplant (BMT) is the only cure for many life-threatening diseases, Dr Bhat said: 'For more than 100 potentially life-threatening diseases, bone marrow transplant or blood stem cell transplant is the only cure.
'Bad cells taken out'
These diseases range from cancers such as leukaemia, lymphoma, solid cancers to genetic disorders of blood forming cells and immune system like thalassemia major, sickle cell anaemia, severe immunodeficiency disorders.
With increasing number of haematological disorders, the number of patients requiring a blood stem cell transplant is also increasing. One of the major differences between bone marrow transplant and solid organ transplants like liver and kidney is that in BMT we need to match HLA of the patient and the donor.
The chance of a patient finding a matched donor within a family is only 25 per cent to 30 per cent - this leaves about 70 per cent of patients needing a BMT for the cure of their disease but don't have a matching donor'.
The younger sister was fortunate her brother was a HLA match who could donate - but he was only 11 months old! Extracting marrow stem cells from a donor who is an infant was a clinical challenge.
The team at Narayana Health City came up with an innovative plan of taking the bone marrow from the donor at two different time points, around four to six weeks apart, in order to have adequate marrow for a transplant.
The transplant was performed in March this year making the 11-month-old infant the youngest donor to have donated bone marrow for his sister. The girl is now completely cured of Thalassemia.
However, her elder sister was not so lucky as she couldn't get a fully matched donor. Therefore, her transplant was even more challenging. She did not have an HLA matched donor either in the family or anywhere in the world. The next possibility was a Haplo-identical transplant.
Doctors at Mazumdar Shaw Cancer Centre at Narayana Health City decided to use the stem cells of the father who was a half match with the elder daughter. A new technique was used in haplo (half matched) transplant as the donor stem cells were not fully matching the patient.
'Her bad cells were taken out in a procedure called TCR alpha-beta depletion and only the good cells were given to the patient', explained Dr Bhat. 'This avoids the risk of donor cells attacking the patient's body.'
Although this technique helps in the above mentioned mechanism, it would delay the immune recovery, which would put them at risk of serious infections.
'To address this issue of slow immune recovery, CD45RA depletion is an additional technique recently introduced,' Dr Bhat said. 'This helps us to give memory cells, which can fight infections in the patient.'
The transplant using this technique was performed on the elder girl in June this year and she is also now completely cured of her disease.
|Printer friendly Cite/link Email Feedback|
|Publication:||The Phnom Penh Post (Phnom Penh, Cambodia)|
|Date:||Sep 17, 2018|
|Previous Article:||Deals 'worth $80M' signed at China-Asean expo.|
|Next Article:||Alvarez ready for rematch after Golovkin dethroned.|